689
Participants
Start Date
November 19, 2020
Primary Completion Date
October 30, 2023
Study Completion Date
August 19, 2024
Brolucizumab 6 mg
3 x q6w loading injections, followed by q12w maintenance through Week 90
Panretinal photocoagulation laser
initial treatment in 1-4 sessions up to Week 12, followed with additional PRP treatment as needed
Novartis Investigative Site, Hualien City
Novartis Investigative Site, Caba
Novartis Investigative Site, Makati
Novartis Investigative Site, Makati
Novartis Investigative Site, Pasig
Novartis Investigative Site, Strathfield
Novartis Investigative Site, Parramatta
Novartis Investigative Site, Liverpool
Novartis Investigative Site, Albury
Novartis Investigative Site, Bundang Gu
Erie Retinal Surgery, Erie
Cumberland Valley Retina Consultants, Hagerstown
Novartis Investigative Site, Tijuana
Virginia Eye Consultants, Norfolk
Charleston Neuroscience Institute, Ladson
Florida Retina Institute, Jacksonville
Eye Center of North Florida, Panama City
Florida Retina Institute, Orlando
Advanced Research LLC, Deerfield Beach
Rand Eye Institute, Deerfield Beach
MedEye Associates, Miami
Pinnacle Research Institute, Fort Lauderdale
Fort Lauderdale Eye Institute, Plantation
Blue Oc Clin Res at Palm Bch Eye Ct, Lakeland
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Izmir
Southeastern Retina Associates P C, Knoxville
University of Mississippi Med Ctr, Jackson
Retina Associates Of Cleveland, Cleveland
Midwest Eye Institute, Indianapolis
John-Kenyon American Eye Institute PC, New Albany
Retina Associates, Elmhurst
Retina Associates PA, Lenexa
Dean McGee Eye Institute, Oklahoma City
Texas Retina Associates, Fort Worth
Retina Consultants of Houston PA, Houston
Retina And Vitreous Of Texas, Bellaire
Retina Consultants TX Rsrch Ctr, Bellaire
Medical Center Opthamology Assoc, San Antonio
Retina Associates Of South Texas PA, San Antonio
Valley Retina Institute PA, Harlingen
Austin Retina Associates, Austin
Texan Eye P A, Austin
Novartis Investigative Site, Kaohsiung City
Retina Associates SW, Tucson
Retina- Vitreous Assoc Medical Group, Beverly Hills
Premiere Practice Management LLC, Torrance
Retina Consultants of Southern California, Redlands
Salehi Retina Institute, Huntington Beach
Retina Consultants of Orange County, Fullerton
Miramar Eye Specialists, Ventura
Cascade Medical Research Institute, Springfield
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Shenyang
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Changchun
Novartis Investigative Site, Chandigarh
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Nanjing
Novartis Investigative Site, Nantong
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Wenzhou
Novartis Investigative Site, Cheboksary
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Ulyanovsk
Novartis Investigative Site, Sterlitamak
Novartis Investigative Site, Shantou
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Tirunelveli
Novartis Investigative Site, Coimbatore
Novartis Investigative Site, Omsk
Novartis Investigative Site, Daegu
Novartis Investigative Site, Xi'an
Novartis Investigative Site, Santiago
Lundquist Inst BioMed at Harbor, Torrance
National Ophthalmic Research Institute, Fort Myers
Novartis Investigative Site, Ciudad Autonoma de Bs As
Novartis Investigative Site, Rosario
Novartis Investigative Site, CABA
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, Blumenau
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Sorocaba
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Toronto
Novartis Investigative Site, Boisbriand
Novartis Investigative Site, Québec
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Nagakute
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Sakura
Novartis Investigative Site, Yoshida-gun
Novartis Investigative Site, Kurume
Novartis Investigative Site, Kōriyama
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Kita-gun
Novartis Investigative Site, Tsu
Novartis Investigative Site, Matsumoto
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Chiyoda-ku
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Meguro-ku
Novartis Investigative Site, Akita
Novartis Investigative Site, Kobe
Novartis Investigative Site, Osaka
Novartis Investigative Site, Ciudad de
Novartis Investigative Site, Mexico City
Emanuelli Research and Development Center LLC, Arecibo
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY